In human breast cancer cells, treatment with the flavones apigenin and luteolin induced FOXO3a expression by inhibiting AKT phosphorylation, leading to increased expression of FOXO3a target genes p21 and p27 and ultimately suppressing cell proliferation [61]. Here, FOXO3 is linked to breast cancer.